Concurrent Disseminated Nocardiosis and GI Mucormycosis in a Stem-Cell Transplantation Recipient

J Clin Oncol. 2016 Apr 1;34(10):e84-6. doi: 10.1200/JCO.2013.51.4042. Epub 2014 Jul 28.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / microbiology
  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / microbiology
  • Diarrhea / microbiology
  • Drug Therapy, Combination
  • Enterocolitis / microbiology
  • Fatal Outcome
  • Gastrointestinal Diseases / diagnosis*
  • Gastrointestinal Diseases / drug therapy
  • Gastrointestinal Diseases / etiology
  • Gastrointestinal Diseases / microbiology*
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Intestinal Perforation / microbiology
  • Lung Diseases / diagnosis*
  • Lung Diseases / etiology
  • Lung Diseases / microbiology*
  • Male
  • Middle Aged
  • Mucormycosis / diagnosis*
  • Mucormycosis / drug therapy
  • Nocardia / isolation & purification
  • Nocardia Infections / diagnosis*
  • Nocardia Infections / drug therapy
  • Opportunistic Infections / diagnosis*
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / microbiology
  • Peripheral Blood Stem Cell Transplantation*
  • Transplant Recipients*

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antiviral Agents
  • Immunosuppressive Agents